40 results
424B3
INM
InMed Pharmaceuticals Inc
13 Nov 23
Prospectus supplement
5:05pm
commercializes such products. We access rare cannabinoids via all non-extraction approaches, including chemical synthesis, biosynthesis and our proprietary
424B3
yqcags0fk67g
19 Oct 22
Prospectus supplement
6:10am
424B3
757ao00
6 Jul 22
Prospectus supplement
2:43pm
424B5
v9lrx8 wmk
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
tdkud 3372j
25 Apr 22
Prospectus supplement
5:02pm
424B3
4pbz28p68pck8ippc36
7 Apr 22
Prospectus supplement
4:46pm